L E T T E R T O T H E E D I T O R
To the Editor:ÐIn their recent JGIM paper on eating disorders, Walsh et al. discussed many key issues in diagnosis and clinical management. 1 There are a few important issues which are worthy of additional emphasis. First, one of the remarkable findings in anorexia nerovsa is the consistent finding of normal blood chemistry tests despite large amounts of weight loss. The presence of hypokalemia or a metabolic alkalosis should raise concern that the anorectic patient may also be surreptitiously purging. 2 In anorectic patients, however, the presence of normal chemistry values should not in any way independently influence decisions regarding the necessary intensity of treatment. Second, the authors discuss in detail the issue of hormone replacement therapy in the anorectic patient with amenorrhea but only have a single sentence about calcium supplementation. As general internists, one of the most important roles we can serve is to be vigilant about aggressively addressing the potential dire consequences of osteoporosis. There is no doubt that weight restoration and resumption of menses are the optimal treatments; however anorexia nervosa appears to be a low turnover state associated with increased bone resorption and high serum cortisol levels. 3 The overall equivocal benefit of estrogen therapy in anorexia nervosa is different than its proven efficacy in post-menopausal women. 4 Rather, calcium supplementation (1500 mg per day) along with Vitamin D (400 IU per day) should be prescribed, especially if cortisol excess is indeed involved. 5 When bone density is found to be reduced despite adequate calcium and Vitamin D intake, consideration should be given to bisphosphonates Ð given the lifelong risk of fractures and the beneficial effect of bisphosphonates Ð to prevent steroid-induced osteoporosis. 6 Finally, in bulimic patients there is discussion about the high aldosterone state and its associated potassium losses as a result of purging behaviors. A common mistake is to vigorously replete potassium without adequate attention to the volume status of the patient. The efficacy of potassium repletion for their hypokalemia will be abrogated unless there is concomitant repletion of the volume status with saline containing fluids. Otherwise the ambient levels of circulating aldosterone remain high and the stimulus for continued potassium excretion remains untreated. However, the fluid repletion must be restrained during this sodium-avid state, so as not to result in the accumulation of marked lower extremity edema for patients with such an abnormal preoccupation with their body image.
Because of the litany of potential medical complications associated with eating disorders, the general internist has an invaluable role to point out the reality and severity of these chronic illnesses, while diligently monitoring and assessing the patient's physical status.ÐPHILIP S. MEHLER, MD, Denver Health Medical Center, Denver, Colo.
In Reply:ÐWe agree with Dr. Mehler's point that blood chemistry tests can be completely normal even with severe weight loss, especially in the absence of recent induced vomiting. Treatment decisions, including the need for hospitalization should not be based upon the presence of abnormal laboratory values. Likewise, in the bulimic patients with volume depletion and hypokalemia, both electrolyte and fluid status must be addressed.
Adequate calcium supplementation is important for all women, including those with anorexia nervosa, given the overall low rates of adequate calcium intake in women in our society. 1 While calcium is necessary to prevent osteoporosis, data clearly indicate that it is insufficient to prevent osteoporosis in glucocorticoid-induced or in estrogen deficit osteoporosis. 2, 3 No studies have addressed the use of calcium supplementation in women with anorexia nervosa. While bisphosphonates have been shown to be of benefit in glucocorticoidinduced osteoporosis, they have been studied primarily in normal or overweight, postmenopausal women, 3±4 and it is unknown if these benefits can be extrapolated to women with anorexia nervosa. Furthermore, there is at least some theoretic concern about the long-term use of biphosphonates in very young patients since they are known to function in part through apoptosis of osteoclasts. 
